FMTX - Forma Therapeutics Holdings Inc. (FMTX) CEO Frank Lee on Q1 2022 Results - Earnings Call Transcript

Forma Therapeutics Holdings Inc. (FMTX) Q1 2022 Earnings Conference Call May 6, 2022, 8:00 AM ET Company Participants Frank Lee – President and Chief Executive Officer Mario Corso – Senior Director Investor Relations Patrick Kelly – Chief Medical Officer Dave Cook – Chief Scientific Officer Conference Call Participants Maury Raycroft – Jefferies Mark Breidenbach – Oppenheimer Robin Garner – Craig Hallum Presentation Operator Welcome to the Forma Therapeutics, First Quarter 2022 Financial Results and Business Update Conference Call. All participants are currently in listen-only mode. Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions]. As a reminder, this call is being recorded today May 6, 2022. I would now like to turn the conference over to Mario Corso, please go ahead. Mario Corso Thank you, Gigi. This is Mario Corso, Senior Director of Investor Relations at Forma. Good morning to our listeners and welcome to today's call

For further details see:

Forma Therapeutics Holdings Inc. (FMTX) CEO Frank Lee on Q1 2022 Results - Earnings Call Transcript